Skip to main content

Table 4 Proportions of coronary patients and high-risk individuals achieving the targets at one year according to DM status

From: Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial)

 

Coronary patients

High-risk individuals

 

DM

Non-DM

Adjusted OR (95% CI)a

P value

DM

Non-DM

Adjusted OR (95% CI)a

P value

Non-Smokers*

22/38 (57.9)

111/180 (61.7)

1.34 (0.69, 2.61)

0.388

271/317 (85.5)

486/712 (68.3)

0.55 (0.29, 1.07)

0.077

SF target

25/51 (49.0)

153/262 (58.4)

0.50 (0.16, 1.57)

0.237

    

Oily fish target

28/125 (22.4)

118/621 (19.0)

1.42 (0.85, 2.37)

0.185

29/313 (9.3)

84/709 (11.9)

0.58 (0.34, 0.98)

0.043

Fish target

121/179 (67.6)

531/776 (68.4)

0.79 (0.51, 1.22)

0.287

257/334 (76.9)

567/774 (73.3)

1.07 (0.74, 1.54)

0.723

Fruit/Veg target

114/144 (79.2)

501/683 (73.4)

1.34 (0.82, 2.18)

0.237

263/317 (82.9)

538/714 (75.4)

1.18 (0.80, 1.73)

0.395

Phy. Activity target

70/144 (48.6)

391/680 (57.5)

0.73 (0.50, 1.07)

0.103

206/313 (65.8%)

536/707 (75.8)

0.68 (0.49, 0.92)

0.011

Ideal WC Females

5/49 (10.2)

48/184 (26.1)

0.45 (0.12, 1.72)

0.241

13/161 (8.1)

98/344 (28.5)

0.48 (0.21, 1.07)

0.072

Ideal WC Males

30/95 (31.6)

210/497 (42.3)

0.83 (0.45, 1.52)

0.550

39/146 (26.7)

157/360 (43.6)

0.65 (0.36, 1.17)

0.151

BMI target

19/144 (13.2)

212/677 (31.3)

0.31 (0.15, 0.65)

0.002

31/313 (9.9)

198/706 (28.1)

0.49 (0.26, 0.90)

0.022

TC <5 mmol/l

101/137 (73.7)

490/661 (74.1)

0.79 (0.50, 1.25)

0.320

143/297 (48.2)

155/678 (22.9)

2.49 (1.82, 3.41)

<0.001

LDL <3 mmol/l

93/126 (73.0)

419/590 (71.0)

0.93 (0.59, 1.47)

0.770

168/290 (57.9)

205/668 (30.7)

2.43 (1.78, 3.33)

<0.001

BP <140/90 mmHg

77/144 (53.5)

502/678 (74.0)

0.47 (0.31, 0.72)

<0.001

210/313 (67.1)

470/707 (66.5)

0.91 (0.66, 1.

0.546

BP <130/85 mmHg

56/144 (38.9)

348/678 (51.3)

0.78 (0.52, 1.17)

0.234

120/313 (38.4)

242/707 (34.2)

1.16 (0.84, 1.60)

0.357

BB

111/130 (85.4)

525/630 (83.3)

1.10 (0.56, 2.16)

0.774

72/139 (51.8)

107/513 (20.9)

0.83 (0.34, 2.03)

0.688

ACE/ARB

106/134 (79.1)

384/588 (65.3)

2.11 (1.11, 3.99)

0.021

164/217 (75.6)

223/546 (40.8)

0.84 (0.43, 1.64)

0.605

Anti-platelets

134/140 (95.7)

644/665 (96.8)

0.65 (0.22, 1.88)

0.422

63/134 (47.0)

74/496 (14.9)

2.04 (0.90, 4.61)

0.087

Statins

123/135 (91.1)

603/646 (93.3)

0.55 (0.26, 1.17)

0.121

147/209 (70.3)

236/586 (40.3)

1.46 (0.94, 2.27)

0.088

  1. Data are n/N (%); aodds ratios adjusted for age and variable at baseline (95% confidence intervals). *also adjusted for smoking in the month prior to the event; ACEI/ARB- angiotensin converting enzyme inhibitor/angiotensin receptor blocker; BB- beta blocker; BMI- body mass index; CCB- calcium channel blocker; DBP- diastolic blood pressure; LDL- low density lipoprotein cholesterol; SBP- systolic blood pressure; SF- saturated fat; TC- total cholesterol; TG- triglyceride.